KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) Invested Capital (2016 - 2025)

Historic Invested Capital for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $64.2 billion.

  • Abbott Laboratories' Invested Capital rose 1635.13% to $64.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $64.2 billion, marking a year-over-year increase of 1635.13%. This contributed to the annual value of $62.0 billion for FY2024, which is 1592.34% up from last year.
  • Latest data reveals that Abbott Laboratories reported Invested Capital of $64.2 billion as of Q3 2025, which was up 1635.13% from $64.3 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Invested Capital peaked at $64.3 billion during Q2 2025, and registered a low of $34.3 billion during Q1 2021.
  • Its 5-year average for Invested Capital is $49.8 billion, with a median of $53.5 billion in 2023.
  • Per our database at Business Quant, Abbott Laboratories' Invested Capital surged by 7578.36% in 2021 and then crashed by 97.86% in 2024.
  • Abbott Laboratories' Invested Capital (Quarter) stood at $49.6 billion in 2021, then increased by 4.95% to $52.0 billion in 2022, then increased by 2.84% to $53.5 billion in 2023, then increased by 15.92% to $62.0 billion in 2024, then grew by 3.51% to $64.2 billion in 2025.
  • Its last three reported values are $64.2 billion in Q3 2025, $64.3 billion for Q2 2025, and $62.3 billion during Q1 2025.